Furthermore, disruption of adherens junctions, including E-cadherin and -catenin, rapidly decreases gap junction plaques, leading to reduced Cx32 levels
However, patients already at higher baseline bleeding risk (due to age, ulcer history, or NSAIDs) should discuss semaglutide use with their anticoagulation team
In March 2024, the FDA approved resmetirom for MASH patients with liver scarring
BPC-157 completely reversed the deleterious effects of systemic methylprednisolone on ligament healing, suggesting protective mechanisms that maintain healing capacity despite anti-inflammatory suppression
Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: integrated activities of hepatic lipid regulatory enzymes